首页> 美国卫生研究院文献>American Journal of Translational Research >Long non coding RNA NRON inhibited breast cancer development through regulating miR-302b/SRSF2 axis
【2h】

Long non coding RNA NRON inhibited breast cancer development through regulating miR-302b/SRSF2 axis

机译:长期非编码RNA符NRON通过调节MIR-302B / SRSF2轴来抑制乳腺癌发育

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aims: Long noncoding RNA NRON has been investigated in various tumors, such as hepatocellular carcinoma. However, the role of lncRNA NRON in breast cancer remains unclear. The aim of this study was to explore the function and mechanism of lncRNA NRON in breast cancer. Materials and methods: Overexpression and knockdown vectors were constructed. Proliferation and invasion were measured to evaluate the function of lncRNA NRON. A dual-luciferase reporter assay was utilized to analyze the potential binding target of lncRNA NRON. A rescue experiment was performed to verify the relationship between lncRNA NRON and SRSF2. Results: Our results showed that the expression of lncRNA NRON was significantly downregulated in breast cancer tissues. Overexpression of lncRNA NRON significantly inhibited proliferation and invasion in breast cancer cell lines. Knockdown of lncRNA NRON promoted breast cancer development. We also provided evidence that lncRNA NRON negatively regulated miR-302b. Moreover, we identified SRSF2 as a downstream target of miR-302b. Conclusion: Overall, we performed a comprehensive analysis to indicate that the lncRNA NRON/miR-302b/SRSF2 axis plays an important role in breast cancer. Our study is the first to prove that lncRNA NRON functions as a tumor suppressor in breast cancer.
机译:目的:在各种肿瘤中研究了长时间的RNA核,如肝细胞癌。然而,LNCRNA胆管在乳腺癌中的作用仍然不清楚。本研究的目的是探讨LNCRNA胆管在乳腺癌中的功能和机制。材料和方法:构建过表达和敲低载体。测量增殖和侵袭以评估LNCRNA符号的功能。利用双荧光素酶报告器测定法分析LNCRNA胆管的潜在结合靶标。进行救援实验以验证LNCRNA符号与SRSF2之间的关系。结果:我们的研究结果表明,乳腺癌组织中LNCRNA胆管的表达明显下调。 LNCRNA胆管的过度表达显着抑制乳腺癌细胞系中的增殖和侵袭。 LNCRNA rugkddown促进乳腺癌发育。我们还提供了证据表明LNCRNA rnron负调节miR-302b。此外,我们将SRSF2识别为miR-302b的下游靶标。结论:总体而言,我们进行了全面的分析,表明LNCRNA符号/ miR-302b / srsf2轴在乳腺癌中起重要作用。我们的研究是第一个证明LNCRNA rnron用作乳腺癌肿瘤抑制剂的功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号